Dimov AV, Nguyen TD, Spincemaille P, Sweeney EM, Zinger N, Kovanlikaya I, Kopell BH, Gauthier SA, Wang Y.
2022.
Global cerebrospinal fluid as a zero-reference regularization for brain quantitative susceptibility mapping.. J Neuroimaging. 32(1):141-147.
Perumal J, Balabanov R, Su R, Chang R, Balcer LJ, Galetta SL, Avila RL, Rutledge D, Fox RJ.
2022.
Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.. CNS Drugs. 36(9):977-993.
Rúa SMHurtado, Kaunzner UW, Pandya S, Sweeney E, Tozlu C, Kuceyeski A, Nguyen TD, Gauthier SA.
2022.
Lesion features on magnetic resonance imaging discriminate multiple sclerosis patients.. Eur J Neurol. 29(1):237-246.
Dimov AV, Gillen KM, Nguyen TD, Kang J, Sharma R, Pitt D, Gauthier SA, Wang Y.
2022.
Magnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation.. Tomography. 8(3):1544-1551.
Parauda SC, Zhang C, Omran SSalehi, Schweitzer AD, Murthy SB, Merkler AE, Navi BB, Iadecola C, Kamel H, Parikh NS.
2022.
Risk of Stroke After Posterior Reversible Encephalopathy Syndrome.. Stroke. :101161STROKEAHA122038673.
Simonetto M, Wechsler PM, Merkler AE.
2022.
Stroke Treatment in the Era of COVID-19: a Review.. Curr Treat Options Neurol. :1-17.
Kim J, Nguyen TD, Zhang J, Gauthier SA, Marcille M, Zhang H, Cho J, Spincemaille P, Wang Y.
2022.
Subsecond accurate myelin water fraction reconstruction from FAST-T data with 3D UNET.. Magn Reson Med. 87(6):2979-2988.
Dimov AV, Nguyen TD, Gillen KM, Marcille M, Spincemaille P, Pitt D, Gauthier SA, Wang Y.
2022.
Susceptibility source separation from gradient echo data using magnitude decay modeling.. J Neuroimaging. 32(5):852-859.
Pitt D, Lo CHung, Gauthier SA, Hickman RA, Longbrake E, Airas LM, Mao-Draayer Y, Riley C, De Jager PLawrence, Wesley S et al..
2022.
Toward Precision Phenotyping of Multiple Sclerosis.. Neurol Neuroimmunol Neuroinflamm. 9(6)